DHR Danaher Corporation Common Stock
About Danaher Corporation Common Stock Company overview from Wikipedia
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
Read more
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle. The name came from a river in Montana.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
DHR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DHR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| June 26, 2026 | $0.4000 |
| March 27, 2026 | $0.4000 |
| Dec. 26, 2025 | $0.3200 |
| Sept. 26, 2025 | $0.3200 |
| June 27, 2025 | $0.3200 |
| March 28, 2025 | $0.3200 |
| Dec. 27, 2024 | $0.2700 |
| Sept. 27, 2024 | $0.2700 |
| June 28, 2024 | $0.2700 |
| March 27, 2024 | $0.2700 |
| Dec. 28, 2023 | $0.2400 |
| Oct. 11, 2023 | $0.2700 |
| June 29, 2023 | $0.2394 |
| March 30, 2023 | $0.2394 |
| Dec. 29, 2022 | $0.2216 |
| Sept. 29, 2022 | $0.2216 |
| June 23, 2022 | $0.2216 |
| March 24, 2022 | $0.2216 |
| Dec. 29, 2021 | $0.1862 |
| Sept. 29, 2021 | $0.1862 |
DHR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 12 37.5%
- Buy 15 46.9%
- Hold 5 15.6%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
23 analysts · 2026-08-21Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $1.94 | $1.85 | 0.09% |
| March 31, 2026 | $2.06 | $1.96 | 0.10% |
| Dec. 31, 2025 | $2.23 | $2.17 | 0.06% |
| Sept. 30, 2025 | $1.89 | $1.74 | 0.15% |
| June 30, 2025 | $1.80 | $1.66 | 0.14% |
| March 31, 2025 | $1.88 | $1.66 | 0.22% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Cash Flow 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Growth Rates 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Income Statement 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | -1,430,800,000 | 710,700,000 | 716,500,000 | 716,300,000 | -1,470,200,000 | 723,000,000 | 737,600,000 | 740,600,000 | -1,469,600,000 | 739,400,000 | 737,300,000 | 729,400,000 | 1,300,000 | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | -1,437,500,000 | 713,700,000 | 719,100,000 | 720,800,000 | -1,483,200,000 | 729,400,000 | 742,400,000 | 748,600,000 | -1,484,700,000 | 745,900,000 | 744,700,000 | 737,200,000 | 100,000 | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Balance Sheet 24
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Cash Flow 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.20B | $23.68B | · | $23.53B | $23.22B | $23.08B | · | $23.74B | $23.57B | $23.74B | · | $24.62B | $25.45B | $26.07B | · | $26.74B | |
| Net Income TTM | $3.36B | $3.45B | · | $3.23B | $3.23B | $3.77B | · | $3.94B | $4.23B | $4.77B | · | $5.26B | $5.81B | $6.43B | · | $6.13B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 41.6 | 37.7 | · | 41.3 | 44.9 | 40.3 | · | 52.6 | 44.4 | 42.3 | · | 27.7 | 25.0 | 24.1 | · | 27.9 | |
| P/S | 5.7 | 5.4 | · | 5.5 | 6.1 | 6.4 | · | 8.4 | 7.7 | 7.8 | · | 6.6 | 6.2 | 6.3 | · | 6.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| P / FCF | · | 118.4 | · | · | · | 139.8 | · | · | · | 127.7 | · | · | · | 97.4 | · | · | |
| Earnings Yield | 2.4% | 2.6% | · | 2.4% | 2.2% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 3.6% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Gross Margin % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Operating Margin % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Diluted EPS | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 2,341 filers · $71.5B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 148 (-55 vs prior Q) | 181 (-73 vs prior Q) | 686 (-80 vs prior Q) | 988 (+62 vs prior Q) | +16.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $7,881,505,437 | 41,377,076 | 11.02% | Shares |
| STATE STREET CORP | $5,431,565,288 | 28,456,019 | 7.60% | Shares |
| FMR LLC | $3,977,715,242 | 20,882,587 | 5.56% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $3,015,682,979 | 15,832,019 | 4.22% | Shares |
| Capital International Investors | $2,953,960,497 | 15,504,420 | 4.13% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,705,808,973 | 14,205,213 | 3.78% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,313,841,539 | 12,214,999 | 3.24% | Shares |
| Capital Research Global Investors | $2,060,650,455 | 10,818,030 | 2.88% | Shares |
| NORGES BANK | $1,816,780,335 | 9,537,906 | 2.54% | Shares |
| EAGLE CAPITAL MANAGEMENT LLC | $1,783,176,557 | 9,361,490 | 2.49% | Shares |
| GENERATION INVESTMENT MANAGEMENT LLP | $1,287,948,806 | 6,761,596 | 1.80% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983,459,478 | 5,163,059 | 1.38% | Shares |
| Fisher Asset Management, LLC | $854,260,080 | 4,484,774 | 1.19% | Shares |
| FLOSSBACH VON STORCH SE | $747,259,707 | 3,923,035 | 1.04% | Shares |
| PARNASSUS INVESTMENTS, LLC | $699,862,950 | 3,674,207 | 0.98% | Shares |
| Holocene Advisors, LP | $684,356,163 | 3,592,798 | 0.96% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $674,795,972 | 3,542,608 | 0.94% | Shares |
| D1 Capital Partners L.P. | $434,682,789 | 2,282,039 | 0.61% | Shares |
| FIRST MANHATTAN CO. LLC. | $429,106,102 | 2,248,424 | 0.60% | Shares |
| BlackRock, Inc. | $424,712,304 | 2,229,695 | 0.59% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $423,080,600 | 2,221,129 | 0.59% | Shares |
| GOLDMAN SACHS GROUP INC | $412,955,174 | 2,167,971 | 0.58% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410,455,346 | 2,154,842 | 0.57% | Shares |
| MILLENNIUM MANAGEMENT LLC | $407,739,012 | 2,140,587 | 0.57% | Shares |
| Castle Hook Partners LP | $404,836,478 | 2,125,349 | 0.57% | Shares |
| AMERIPRISE FINANCIAL INC | $392,617,529 | 2,061,025 | 0.55% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $389,240,356 | 2,043,471 | 0.54% | Shares |
| 1832 Asset Management L.P. | $364,584,815 | 1,914,032 | 0.51% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $359,830,054 | 1,889,070 | 0.50% | Shares |
| LAZARD ASSET MANAGEMENT LLC | $355,388,763 | 1,865,754 | 0.50% | Shares |
| Swiss National Bank | $342,198,844 | 1,796,508 | 0.48% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $341,443,781 | 1,792,544 | 0.48% | Shares |
| NEUBERGER BERMAN GROUP LLC | $339,224,793 | 1,780,339 | 0.47% | Shares |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $318,260,440 | 1,670,835 | 0.45% | Shares |
| BANK OF AMERICA CORP /DE/ | $301,393,888 | 1,582,286 | 0.42% | Shares |
| Legal & General Group Plc | $295,737,157 | 1,552,589 | 0.41% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $295,010,472 | 1,548,774 | 0.41% | Shares |
| FIL Ltd | $290,578,764 | 1,525,508 | 0.41% | Shares |
| National Pension Service | $285,900,766 | 1,500,949 | 0.40% | Shares |
| VAN ECK ASSOCIATES CORP | $281,058,192 | 1,475,526 | 0.39% | Shares |
| Southpoint Capital Advisors LP | $266,672,000 | 1,400,000 | 0.37% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $263,806,038 | 1,384,954 | 0.37% | Shares |
| Anomaly Capital Management, LP | $260,066,154 | 1,365,320 | 0.36% | Shares |
| Vanguard Global Advisers, LLC | $258,865,177 | 1,359,015 | 0.36% | Shares |
| RAYMOND JAMES FINANCIAL INC | $257,409,127 | 1,351,371 | 0.36% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $246,675,000 | 1,295,020 | 0.34% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $241,732,034 | 1,269,068 | 0.34% | Shares |
| Sustainable Growth Advisers, LP | $239,075,067 | 1,255,119 | 0.33% | Shares |
| AVIVA PLC | $237,495,036 | 1,246,824 | 0.33% | Shares |
| California Public Employees Retirement System | $235,582,426 | 1,236,783 | 0.33% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $232,825,990 | 1,222,312 | 0.33% | Shares |
| UBS Group AG | $222,739,883 | 1,169,361 | 0.31% | Shares |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $218,286,080 | 1,145,979 | 0.31% | Shares |
| Nuveen, LLC | $214,912,083 | 1,128,266 | 0.30% | Shares |
| PRUDENTIAL FINANCIAL INC | $213,476,650 | 1,120,730 | 0.30% | Shares |
| KING LUTHER CAPITAL MANAGEMENT CORP | $206,309,650 | 1,083,104 | 0.29% | Shares |
| MONTRUSCO BOLTON INVESTMENTS INC. | $202,781,580 | 1,064,582 | 0.28% | Shares |
| MACKENZIE FINANCIAL CORP | $198,886,263 | 1,044,132 | 0.28% | Shares |
| ROYAL LONDON ASSET MANAGEMENT LTD | $191,867,454 | 1,007,284 | 0.27% | Shares |
| Mirova US LLC | $190,479,238 | 999,996 | 0.27% | Shares |
| RHUMBLINE ADVISERS | $189,703,347 | 995,923 | 0.27% | Shares |
| BLAIR WILLIAM & CO/IL | $184,974,108 | 971,095 | 0.26% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $184,610,866 | 973,686 | 0.26% | Shares |
| CITADEL ADVISORS LLC | $179,754,833 | 943,694 | 0.25% | Shares |
| BARCLAYS PLC | $173,566,710 | 911,207 | 0.24% | Shares |
| Qube Research & Technologies Ltd | $160,863,027 | 844,514 | 0.22% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $158,843,698 | 809,642 | 0.22% | Shares |
| JANE STREET GROUP, LLC | $157,469,816 | 826,700 | 0.22% | Call option |
| Unisphere Establishment | $154,098,320 | 809,000 | 0.22% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $144,885,945 | 760,636 | 0.20% | Shares |
| Balyasny Asset Management L.P. | $144,613,749 | 759,207 | 0.20% | Shares |
| CI INVESTMENTS INC. | $143,569,157 | 753,723 | 0.20% | Shares |
| Focus Partners Wealth | $138,144,377 | 725,093 | 0.19% | Shares |
| Corient Private Wealth LP | $134,474,841 | 705,975 | 0.19% | Shares |
| Squarepoint Ops LLC | $133,894,678 | 702,933 | 0.19% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $131,380,532 | 689,734 | 0.18% | Shares |
| DAVENPORT & Co LLC | $129,567,583 | 678,343 | 0.18% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $128,724,672 | 672,386 | 0.18% | Shares |
| JOHNSON INVESTMENT COUNSEL INC | $124,418,228 | 653,183 | 0.17% | Shares |
| Alecta Tjanstepension Omsesidigt | $123,111,539 | 646,900 | 0.17% | Shares |
| Dorsey Asset Management, LLC | $119,280,671 | 626,211 | 0.17% | Shares |
| Pictet Asset Management Holding SA | $119,219,547 | 625,690 | 0.17% | Shares |
| Aberdeen Group plc | $118,872,663 | 624,069 | 0.17% | Shares |
| FRANKLIN RESOURCES INC | $116,674,905 | 612,531 | 0.16% | Shares |
| ALLIANCEBERNSTEIN L.P. | $114,452,230 | 603,651 | 0.16% | Shares |
| Welch & Forbes LLC | $113,968,746 | 598,324 | 0.16% | Shares |
| JENNISON ASSOCIATES LLC | $113,865,135 | 597,780 | 0.16% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $112,932,032 | 589,589 | 0.16% | Shares |
| BRADLEY FOSTER & SARGENT INC/CT | $111,570,652 | 585,734 | 0.16% | Shares |
| JARISLOWSKY, FRASER Ltd | $109,881,639 | 554,230 | 0.15% | Shares |
| First Pacific Advisors, LP | $107,579,485 | 564,781 | 0.15% | Shares |
| Woodline Partners LP | $107,477,769 | 564,247 | 0.15% | Shares |
| EMINENCE CAPITAL, LP | $106,409,966 | 561,234 | 0.15% | Shares |
| Canoe Financial LP | $106,328,603 | 558,214 | 0.15% | Shares |
| Mariner, LLC | $105,627,587 | 554,431 | 0.15% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $105,203,437 | 552,307 | 0.15% | Shares |
| Third Point LLC | $102,859,200 | 540,000 | 0.14% | Shares |
| Meridiem Capital Partners LP | $102,371,000 | 537,437 | 0.14% | Shares |
| Spear Holdings RSC Ltd | $101,874,609 | 534,831 | 0.14% | Shares |
| PBCay One RSC Ltd | $101,868,133 | 534,797 | 0.14% | Shares |
Company insiders 51 insiders · 24 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | March 1, 2026 A | 37,988 | 0 | 0 | $0 |
| Thomas Patrick Joyce JR | President and CEO | July 24, 2020 M | 203,513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | July 18, 2014 M | 512,199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | May 15, 2026 F | 8,291 | 0 | 2 | $-1,088,686 |
| Matthew Mcgrew | Executive Vice President | March 1, 2026 A | 26,825 | 0 | 1 | $-3,470,835 |
| Bradley R Gray | SVP Strategic Development | March 1, 2026 A | 14,463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | Feb. 4, 2026 A | 14,994 | 0 | 2 | $-4,773,810 |
| Daniel Raskas | SVP - Corporate Development | Feb. 1, 2025 A | 10,524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | May 15, 2024 M | 48,190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | May 15, 2024 F | 87,333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | May 15, 2023 F | 26,165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | Feb. 24, 2022 A | 47,962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | May 21, 2021 S | 16,155 | 0 | 0 | $0 |
| William K Daniel | EVP | Feb. 20, 2020 A | 109,886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | May 10, 2016 A | 113,198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | July 28, 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | May 19, 2015 M | 34,606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | Feb. 21, 2015 F | 174,406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | Jan. 29, 2010 A | 5,010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | Oct. 26, 2007 A | 4,400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | Feb. 1, 2007 M | 75,813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | May 4, 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | Aug. 31, 2004 A | — | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | Jan. 1, 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Director | May 15, 2026 A | 1,359 | 0 | 0 | $0 |
| John T Schwieters | Director | July 15, 2025 M | 19,815 | 0 | 0 | $0 |
| Jessica L Mega | Director | May 15, 2025 A | 3,302 | 0 | 0 | $0 |
| Pardis C Sabeti | Director | Oct. 25, 2024 A | 5,283 | 0 | 0 | $0 |
| Walter G Lohr | Director | Feb. 15, 2024 M | 14,129 | 0 | 0 | $0 |
| Donald J Ehrlich | Director | Feb. 10, 2020 M | 123,203 | 0 | 0 | $0 |
| Robert J Hugin | Director | May 15, 2017 A | 3,576 | 0 | 0 | $0 |
| Mortimer M Caplin | Director | April 26, 2013 A | 83,213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Director | Nov. 30, 2007 M | 368,240 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | 10% owner | Sept. 30, 2023 J | 0 | 0 | 0 | $0 |
| Matthew E Gugino | — | Aug. 4, 2026 A | 11,401 | 0 | 0 | $0 |
| Gregory M Milosevich | — | Aug. 4, 2026 A | 24,467 | 0 | 1 | $-274,573 |
| Montgomery Julie A Sawyer | — | Aug. 4, 2026 A | 22,221 | 0 | 0 | $0 |
| Christopher Paul Riley | — | Aug. 4, 2026 A | 61,472 | 0 | 0 | $0 |
| Christopher Bouda | — | Aug. 4, 2026 A | 9,107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | — | Aug. 4, 2026 A | 32,495 | 0 | 0 | $0 |
| Jonathan Leiken | — | Aug. 4, 2026 A | 12,546 | 0 | 0 | $0 |
| Mitchell P. Rales | — | Aug. 4, 2026 A | 553,228 | 0 | 9 | $-234,561,260 |
| Steven M Rales | — | Aug. 4, 2026 A | 3,605,808 | 0 | 0 | $0 |
| Shane A Sanders | — | July 31, 2026 A | 5,914 | 0 | 0 | $0 |
| Raymond C Stevens | — | July 31, 2026 A | 13,728 | 0 | 0 | $0 |
| Teri List-Stoll | — | July 31, 2026 A | 21,470 | 0 | 2 | $-1,333,322 |
| Feroz Dewan | — | July 31, 2026 A | 4,686 | 0 | 0 | $0 |
| Elias A. Zerhouni | — | July 31, 2026 A | 45,303 | 0 | 0 | $0 |
| Linda P Hefner | — | July 31, 2026 A | 26,829 | 0 | 0 | $0 |
| Alan G Spoon | — | July 31, 2026 A | 124,774 | 0 | 1 | $-237,202 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 9 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 filings | Nov. 2, 2021 | — | Initial filing | — | SEC |
| Steven M. Rales ×6 filings | June 14, 2021 | — | Initial filing | — | SEC |
| Undisclosed reporting person | Oct. 22, 2014 | — | Initial filing | M&A / sale | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 filings | Dec. 9, 2010 | — | Initial filing | — | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 filings | Feb. 5, 2010 | — | Initial filing | — | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 filings | March 30, 2007 | — | Initial filing | — | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | April 23, 2003 | — | Initial filing | — | SEC |
| Undisclosed reporting person, Undisclosed reporting person | June 8, 2001 | — | Initial filing | — | SEC |
| Undisclosed reporting person | May 25, 2001 | — | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 202 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PRCS · Parnassus Funds II | 5.06% | 42,782 NS | June 30, 2026 | N-PORT |
| CVRD · Madison ETFs Trust | 4.29% | 7,200 NS | June 30, 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 3.42% | 7,675 NS | May 31, 2026 | N-PORT |
| MBCC · Northern Lights Fund Trust IV | 3.31% | 33,421 NS | May 31, 2026 | N-PORT |
| BCHP · Principal Exchange-Traded Funds | 3.22% | 36,941 NS | June 30, 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2.66% | 7,557 NS | May 31, 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2.45% | 30,573 NS | April 30, 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2.43% | 3,739 NS | April 30, 2026 | N-PORT |
| YALL · Tidal Trust I | 2.29% | 12,162 NS | May 31, 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2.22% | 8,213 NS | May 31, 2026 | N-PORT |
| IYH · iShares Trust | 2.11% | 376,956 SH | Aug. 21, 2026 | Daily |
| MDEV · First Trust Exchange-Traded Fund VI | 2.06% | 207 NS | June 30, 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 1.92% | 3,881 NS | April 30, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.90% | 1,184 NS | April 30, 2026 | N-PORT |
| THMZ · Lazard Active ETF Trust | 1.88% | 5,346 NS | June 30, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1.84% | 293,052 NS | April 30, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1.79% | 1,914,802 SH | Aug. 19, 2026 | Daily |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.70% | 64,565 SH | Aug. 21, 2026 | Daily |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.68% | 5,006 NS | April 30, 2026 | N-PORT |
| RXL · ProShares Trust | 1.66% | 6,560 NS | May 31, 2026 | N-PORT |
| ANEW · ProShares Trust | 1.66% | 701 NS | May 31, 2026 | N-PORT |
| IXJ · iShares Trust | 1.64% | 331,014 SH | Aug. 21, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 1.62% | 12,545 NS | April 30, 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 1.56% | 10,073 NS | May 31, 2026 | N-PORT |
| SAWG · ETF Series Solutions | 1.38% | 194 NS | April 30, 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1.26% | 146,061 NS | April 30, 2026 | N-PORT |
| PSET · Principal Exchange-Traded Funds | 1.24% | 1,868 NS | June 30, 2026 | N-PORT |
| GRW · TCW ETF Trust | 1.21% | 4,855 NS | April 30, 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1.19% | 3,038 NS | April 30, 2026 | N-PORT |
| GNOM · Global X Funds | 1.17% | 3,573 NS | May 31, 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1.11% | 3,541 NS | April 30, 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1.11% | 144,148 SH | Aug. 21, 2026 | Daily |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1.07% | 6,377 NS | April 30, 2026 | N-PORT |
| FPAG · Investment Managers Series Trust III | 0.99% | 28,133 NS | June 30, 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 0.92% | 1,138 NS | April 30, 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.89% | 8,584 NS | April 30, 2026 | N-PORT |
| ROPE · EA Series Trust | 0.88% | 408 NS | May 29, 2026 | N-PORT |
| SNPV · DBX ETF Trust | 0.78% | 9,793 NS | May 29, 2026 | N-PORT |
| XT · iShares Trust | 0.76% | 138,526 SH | Aug. 21, 2026 | Daily |
| WINN · Harbor ETF Trust | 0.75% | 45,913 NS | April 30, 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0.75% | 12,657 NS | May 31, 2026 | N-PORT |
| BIGY · Tidal Trust II | 0.75% | 1,089 NS | April 30, 2026 | N-PORT |
| PRAY · FIS Trust | 0.74% | 3,267 NS | May 31, 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 0.63% | 60,285 NS | May 31, 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0.58% | 165,000 | Aug. 21, 2026 | Daily |
| MFSG · MFS Active Exchange Traded Funds Tr… | 0.57% | 10,794 NS | May 31, 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0.57% | 400,375 SH | Aug. 19, 2026 | Daily |
| PAPI · Morgan Stanley ETF Trust | 0.56% | 11,779 NS | June 30, 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0.55% | 3,919 NS | May 31, 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0.55% | 6,871 NS | June 30, 2026 | N-PORT |